juluca
viiv healthcare b.v. - dolutegravir de sodiu, clorhidrat de rilpivirină - infecții cu hiv - antivirale pentru uz sistemic - juluca este indicat pentru tratamentul infecției cu virusul imunodeficienței umane de tip 1 (hiv-1) infecții la adulți care sunt virusologic-a suprimat (arn hiv-1.
pemetrexed novamed 100 mg
seacross pharma (europe) limited - irlanda - pemetrexedum - pulb. pt. conc. pt. sol. perf. - 100mg - antimetaboliti analogi ai acidului folic
pemetrexed novamed 500 mg
seacross pharma (europe) limited - irlanda - pemetrexedum - pulb. pt. conc. pt. sol. perf. - 500mg - antimetaboliti analogi ai acidului folic
pemetrexed seacross 500 mg pulbere pentru concentrat pentru soluţie perfuzabilă
seacross pharmaceuticals limited - pemetrexedum - pulbere pentru concentrat pentru soluţie perfuzabilă - 500 mg
pemetrexed seacross 100 mg
seacross pharma (europe) limited - irlanda - pemetrexedum - pulb. pt. conc. pt. sol. perf. - 100mg - antimetaboliti analogi ai acidului folic
pemetrexed seacross 500 mg
seacross pharma (europe) limited - irlanda - pemetrexedum - pulb. pt. conc. pt. sol. perf. - 500mg - antimetaboliti analogi ai acidului folic
tivicay 50 mg comprimate filmate
viiv healtcare uk limited - dolutegravirum - comprimate filmate - 50 mg
tivicay
viiv healthcare bv - dolutegravir - infecții cu hiv - antivirale pentru uz sistemic - tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 6 years of age or older and weighing at least 14 kg. tivicay is indicated in combination with other anti-retroviral medicinal products for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children of at least 4 weeks of age or older and weighing at least 3 kg.
tivicay 50 mg comprimate filmate
viiv healtcare uk limited - dolutegravirum - comprimate filmate - 50 mg
triumeq
viiv healthcare b.v. - dolutegravir sodium, lamivudine, abacavir (as sulfate) - infecții cu hiv - antivirale pentru uz sistemic - triumeq is indicated for the treatment of human immunodeficiency virus (hiv) infected adults, adolescents and children weighing at least 25 kg who are antiretroviral treatment-naïve or are infected with hiv without documented or clinically suspected resistance to any of the three antiretroviral agents in triumeq.